Skip to main content

Find Clinical Trials

Home
Conditions
Microsatellite Instability

Clinical trial condition

Microsatellite Instability

Explore clinical trials studying Microsatellite Instability. Study availability and eligibility vary by location and protocol.

30 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Microsatellite Instability trial results

Completed

Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort Study

NCT03774862

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +24 more
Locations: Not specified

View Trial Details

Completed

Molecular Biology of Anal Cancer in HIV-Positive Patients

NCT00952874

Conditions: Anus Diseases, Anus Neoplasms, Blood-Borne Infections, +35 more
Locations: University Hospital Geneva Geneva, Switzerland

View Trial Details

Active, Not Recruiting

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

NCT03935893

Conditions: Adenocarcinoma, Adenoma, Carcinoma, +46 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor

NCT03607890

Conditions: Genomic Instability, MSI-H Tumors, Microsatellite Instability, +4 more
Locations: Cedars Sinai Medical Center Los Angeles, California, United States

Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

View Trial Details

Active, Not Recruiting

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

NCT03228667

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +79 more
Locations: Alaska Clinical Research Center Anchorage, Alaska, United States

Genesis Cancer Center Hot Springs, Arkansas, United States

Chan Soon-Shiong Institute for Medicine El Segundo, California, United States

MemorialCare Health System Fountain Valley, California, United States

View all 35 locations

View Trial Details

Active, Not Recruiting

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

NCT02628067

Conditions: Adenocarcinoma, Adenoma, Advanced Cancer, +88 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

National Cohort of Colorectal Cancers With Microsatellite Instability

NCT05511688

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +13 more
Locations: Chu Poitiers Poitiers, VIENNE, France

CH Abbeville, France

Chu - Hôpital Sud Amiens, France

Chu - Hôpital Hôtel Dieu Angers, France

View all 14 locations

View Trial Details

Active, Not Recruiting

iRECIST Evaluation's Relevance for DCR in MMR/MSI Metastatic Colorectal Cancer Patients on Nivolumab and Ipilimumab

NCT03350126

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +13 more
Locations: Institut Sainte Catherine Avignon, France

CHRU Besançon Besançon, France

Henri Mondor Hospital Créteil, France

IHFB Levallois-Perret, France

View Trial Details

Active, Not Recruiting

Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma.

NCT04006262

Conditions: Genomic Instability, Localized Oesogastric Adenocarcimona, MSI and or dMMR, +3 more
Locations: CHRU Jean Minjoz Besançon, France

Hôpital Henri Mondor Créteil, France

Institut Hospitalier Franco-Britannique Levallois-Perret, France

CHRU Lille Lille, France

View all 15 locations

View Trial Details

Active, Not Recruiting

TremelImumab aNd Durvalumab For the Non-operatIve Management (NOM) of MSI-high Resectable GC/GEJC.

NCT04817826

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +10 more
Locations: Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Milan, Italy

View Trial Details